Corneal cross-linking pressure changes in keratoconus
Part of Eyes & vision clinical trials.
This study measures eye pressure before and after a treatment called corneal cross-linking for a condition called keratoconus, which thins and bulges the cornea. It aims to see if the treatment affects eye pressure, which can help manage the condition better.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 19 and 35 years old.
- You have been diagnosed with mild keratoconus.
- You do not have any corneal scarring or infections.
- Your cornea is not too thin (at least 400 micrometers at the thinnest point).
- You do not have uveitis, eye allergies, or glaucoma.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies collagen cross-linking, a procedure meant to strengthen a weakened cornea in people with keratoconus. It may help slow the bulging/weakening of the cornea and improve vision, and the study also uses special imaging to check changes over time.
This study tests a same-day procedure that strengthens the cornea (the clear front part of the eye) in both eyes using a special light treatment, called cross-linking. It may help slow or stop the progression of keratoconus, a condition where the cornea becomes cone-shaped and causes blurry vision.
This study looks at how different laser eye surgery techniques affect eye pressure (intraocular pressure) after the procedure. If you have moderate nearsightedness, this could help determine which surgery method is safest for you.
This study tests a procedure called corneal crosslinking to slow or stop the progression of keratoconus or corneal ectasia. It might help keep your cornea stable and prevent further vision loss.
This trial tests a new combined treatment for keratoconus that includes both a surface laser (phototherapeutic keratectomy) and corneal collagen crosslinking (CXL). It may help strengthen your cornea and improve vision.
This study tests whether treating donor corneal tissue with a special light and vitamin drops (called cross-linking) before a transplant helps improve outcomes for people with keratoconus. If you need a corneal transplant, this could strengthen the donor tissue and potentially reduce the need for future procedures.
Hear when a new Keratoconus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.